lonidamine has been researched along with Bile Duct Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boonmars, T; Cha'on, U; Phoomak, C; Sangkhamanon, S; Seubwai, W; Thamrongwaranggoon, U; Wongkham, S | 1 |
1 other study(ies) available for lonidamine and Bile Duct Cancer
| Article | Year |
|---|---|
Targeting hexokinase II as a possible therapy for cholangiocarcinoma.
Topics: Animals; Bile Duct Neoplasms; Cell Division; Cell Line, Tumor; Cholangiocarcinoma; Cricetinae; Disease Progression; Enzyme Inhibitors; Hexokinase; Immunohistochemistry; Indazoles; Opisthorchis | 2017 |